🇺🇸 Recombinant Influenza Vaccine in United States

Recombinant Influenza Vaccine (Recombinant Influenza Vaccine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Recombinant Influenza Vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Recombinant Influenza Vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Recombinant Influenza Vaccine in United States?

Insight Therapeutics, LLC is the originator. The local marketing authorisation holder may differ — check the official source linked above.